Back to Report Store Home

Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth

  • Published: Dec-2012
  • Report Code: GBIHC240MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Rheumatology Therapeutics Market, Global, Revenue Forecasts ($bn), 2005, 2011 & 2018

Figure 2: Rheumatology Therapeutics Market, Global, Revenue Forecasts ($bn), 2005–2018

Figure 3: Rheumatology Therapeutics Market, Global, Annual Cost of Therapy ($), 2005–2018

Figure 4: Rheumatology Therapeutics Market, Global, Treatment Usage Patterns (million), 2005–2018

Figure 5: Rheumatology Therapeutics Market, The US, Revenue Forecasts ($bn), 2005–2018

Figure 6: Rheumatology Therapeutics Market, The US, Annual Cost of Therapy ($), 2005–2018

Figure 7: Rheumatology Therapeutics Market, The US, Treatment Usage Patterns (million), 2005–2018

Figure 8: Rheumatology Therapeutics Market, Top Five Countries of Europe, Revenue Forecasts ($bn), 2005–2018

Figure 9: Rheumatology Therapeutics Market, Top Five Countries of Europe, Revenue Forecasts ($m), 2005–2018

Figure 10: Rheumatology Therapeutics Market, Top Five Countries of Europe, Annual Cost of Therapy ($), 2005–2018

Figure 11: Rheumatology Therapeutics Market, Top Five Countries of Europe, Treatment Usage Patterns (million), 2005–2018

Figure 12: Rheumatology Therapeutics Market, Japan, Revenue Forecasts ($bn), 2005–2018

Figure 13: Rheumatology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2005–2018

Figure 14: Rheumatology Disorders Therapeutics Market, Japan, Treatment Usage Patterns (millions), 2005–2018

Figure 15: Rheumatoid Arthritis Therapeutics Market, Global, Revenue Forecasts ($bn), 2005–2018

Figure 16: Rheumatoid Arthritis Therapeutics Market, Global, Revenue Forecasts by Country ($m), 2005–2018

Figure 17: Rheumatoid Arthritis Therapeutics Market, Global, Annual Cost of Therapy ($), 2005–2018

Figure 18: Rheumatoid Arthritis Therapeutics Market, Global, Treatment Usage Pattern (millions), 2005–2018

Figure 19: Rheumatoid Arthritis Therapeutics Market, Rheumatoid Arthritis, Treatment Flow Algorithm

Figure 20: Rheumatoid Arthritis Therapeutics Market, Drivers and Barriers

Figure 21: Osteoarthritis Therapeutics Market, Global, Revenue Forecasts ($bn), 2005–2018

Figure 22: Osteoarthritis Therapeutics Market, Global, Revenue Forecasts ($m), 2005–2018

Figure 23: Osteoarthritis Therapeutics Market, Global, Annual Cost of Therapy ($), 2005–2018

Figure 24: Osteoarthritis Therapeutics Market, Global, Osteoarthritis Pain Treatment Algorithm

Figure 25: Osteoarthritis Therapeutics Market, Global, Treatment Usage Pattern (millions), 2005–2018

Figure 26: Osteoarthritis Therapeutics Market, Global, Drivers and Barriers

Figure 27: Gout Therapeutics Market, Global, Revenue Forecasts ($m), 2005–2018

Figure 28: Gout Therapeutics Market, Global, Revenue Forecasts by Country ($m), 2005–2018

Figure 29: Gout Therapeutics Market, Global, Annual Cost of Therapy ($), 2005–2018

Figure 30: Gout Therapeutics Market, Global, Treatment Usage Pattern (millions), 2005–2018

Figure 31: Gout Therapeutics Market, Treatment Flow Algorithm for Gout

Figure 32: Gout Therapeutics Market, Global, Drivers and Barriers

Figure 33: Systemic Lupus Erythematosus Therapeutics Market, Global, Revenue Forecasts ($m), 2005–2018

Figure 34: Systemic Lupus Erythematosus Therapeutics Market, Global, Revenue Forecasts by Country ($m), 2005–2018

Figure 35: Systemic Lupus Erythematosus Therapeutics Market, Global, Annual Cost of Therapy ($), 2005–2018

Figure 36: Systemic Lupus Erythematosus Therapeutics Market, Global, Treatment Usage Pattern (‘000), 2005–2018

Figure 37: Systemic Lupus Erythematosus Therapeutics Market, Treatment Flow Algorithm

Figure 38: Systemic Lupus Erythematosus Therapeutics Market, Global, Drivers and Barriers

Figure 39: Rheumatology Therapeutics Market, Global, Pipeline Molecules by Stage of Development, May, 2012

Figure 40: Rheumatology Therapeutics Market, Abbott, SWOT Analysis

Figure 41: Rheumatology Therapeutics Market, Amgen, SWOT Analysis

Figure 42: Rheumatology Therapeutics Market, Pfizer, SWOT Analysis

Figure 43: Rheumatology Therapeutics Market, Janssen Biotech, SWOT Analysis

Figure 44: Rheumatology Therapeutics Market, Merck, SWOT Analysis

Figure 45: Rheumatology Therapeutics Market, Global, Deals by Type of Agreement (%), 2007–2012

Figure 46: Rheumatology Therapeutics Market, Global, Deals by Year, 2007–2012

Figure 47: Rheumatology Therapeutics Market, Global, Deals by Geography (%), 2007–2012

Figure 48: GBI Research Market Forecasting Model

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards